FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Broadrick Dale
2. Issuer Name and Ticker or Trading Symbol

BioRestorative Therapies, Inc. [ BRTX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

3003 BRICK CHURCH PIKE
3. Date of Earliest Transaction (MM/DD/YYYY)

5/9/2019
(Street)

NASHVILLE, TN 37207
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  5/9/2019    P    1000  A $.4  3440512  D   
Common Stock  5/21/2019    P    82040  A $.3910 (1) 3522552  D   
Common Stock  5/23/2019    P    1000  A $.57  3523522  D   
Common Stock  5/23/2019    P    5000  A $.54  3528522  D   
Common Stock  5/24/2019    P    30000  A $.4053 (2) 3558552  D   
Common Stock  6/3/2019    P    5000  A $.39  3563552  D   
Common Stock  6/3/2019    P    3000  A $.37  3566552  D   
Common Stock  6/5/2019    P    500  A $.41  3567052  D   
Common Stock  6/5/2019    P    200  A $.42  3567252  D   
Common Stock  6/6/2019    P    23000  A $.4327 (3) 3590252  D   
Common Stock  6/10/2019    P    2500  A $.48  3592752  D   
Common Stock  6/12/2019    P    25400  A $.36 (4) 3618152  D   
Common Stock  6/13/2019    P    1000  A $.42  3619152  D   
Common Stock  6/13/2019    P    11000  A $.35  3630152  D   
Common Stock  7/29/2019    P    140356  A $.3542 (5) 3770508  D   
Common Stock  7/30/2019    P    100  A $.42  3770608  D   
Common Stock  10/8/2019    P    61971  A $.13  4009399 (6) D   
Common Stock  10/8/2019    P    14000  A $.14  4023399  D   
Common Stock  10/9/2019    P    9000  A $.17  4032399  D   
Common Stock  10/14/2019    P    13000  A $.11  4045399  D   
Common Stock  10/15/2019    P    5000  A $.14  4050399  D   
Common Stock  10/15/2019    P    1000  A $.15  4051399  D   
Common Stock  10/16/2019    P    3333333 (7) A $.15  7384732  D   
Common Stock  10/17/2019    P    30000  A $.12  7414732  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant to acquire Common Stock  $.85  10/16/2019    J        500000   2/19/2019  2/19/2024  Common Stock  500000   (8) 0  D   
Warrant to acquire Common Stock  $.15  10/16/2019    J     500000      2/19/2019  2/19/2024  Common Stock  500000   (8) 500000  D   
Warrant to acquire Common Stock  $.7  10/16/2019    J        500000   2/19/2019  2/19/2020  Common Stock  500000   (9) 0  D   
Warrant to acquire Common Stock  $.15  10/16/2019    J     500000      2/19/2019  2/19/2024  Common Stock  500000   (9) 500000  D   
Warrant to acquire Common Stock  $.85  10/16/2019    J        555556   5/7/2019  5/7/2024  Common Stock  555556   (8) 0  D   
Warrant to acquire Common Stock  $.15  10/16/2019    J     555556      5/7/2019  5/7/2024  Common Stock  555556   (8) 555556  D   
Warrant to acquire Common Stock  $.7  10/16/2019    J        555555   5/7/2019  5/7/2020  Common Stock  555555   (9) 0  D   
Warrant to acquire Common Stock  $.15  10/16/2019    J     555555      5/7/2019  5/7/2024  Common Stock  555555   (9) 555555  D   
Warrant to acquire Common Stock  $.20  10/16/2019    P     3333333      10/16/2019  10/16/2024  Common Stock  3333333  $0  3333333  D   

Explanation of Responses:
(1)  This transaction was executed in multiple trades at prices ranging from $0.35 to $0.51 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(2)  This transaction was executed in multiple trades at prices ranging from $0.39 to $0.42 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(3)  This transaction was executed in multiple trades at prices ranging from $0.41 to $0.53 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(4)  This transaction was executed in multiple trades at prices ranging from $0.35 to $0.49 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(5)  This transaction was executed in multiple trades at prices ranging from $0.32 to $0.40 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(6)  Gives effect to purchases made on August 21, 2019 and August 22, 2019 and reported on a separate Form 4 filed on August 23, 2019, as amended by a Form 4 filed on October 18, 2019.
(7)  Private purchase from issuer.
(8)  The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price.
(9)  The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price and an extended expiration date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Broadrick Dale
3003 BRICK CHURCH PIKE
NASHVILLE, TN 37207

X


Signatures
/s/ Dale Broadrick 10/18/2019
**Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.